Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
The Korean Journal of Internal Medicine
|
May 16, 2018
Albers-Schönberg disease
Li-Ta Keng, Sheng-Kai Liang
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
Sheng-Kai Liang, Jen-Chung Ko, James Chih-Hsin Yang, et al.
Analytical Biochemistry
|
March 17, 2023
Determining plasma and cerebrospinal fluid concentrations of EGFR-TKI in lung cancer patients
Guan-Yuan Chen, Sheng-Kai Liang, Yu-Feng Wei, et al.
ERJ Open Research
|
March 19, 2024
Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients with <i>EGFR</i>-mutated non-small cell lung cancer treated with afatinib
Sheng-Kai Liang, Pin-Fei Wei, Min-Shu Hsieh, et al.
Thorax
|
January 14, 2021
Pulmonary granulomas: give it a whorl
Li-Ta Keng, Wei-Yung Lo, Hsien-Neng Huang, et al.
International Journal of Antimicrobial Agents
|
August 24, 2015
Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014
Meng-Rui Lee, Chia-Jung Tsai, Sheng-Kai Liang, et al.
Oncotarget
|
November 23, 2017
Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma
Sheng-Kai Liang, Min-Shu Hsieh, Meng-Rui Lee, et al.
Journal of Bone and Mineral Metabolism
|
February 11, 2021
LncPVT1 promotes cartilage degradation in diabetic OA mice by downregulating miR-146a and activating TGF-β/SMAD4 signaling
Yan-Zhi Wang, Yao-Li, Sheng-Kai Liang, et al.
Oncotarget
|
May 29, 2018
Prognostic factors of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma: a real-world, large cohort study
Sheng-Kai Liang, Meng-Rui Lee, Wei-Yu Liao, et al.
International Journal of Antimicrobial Agents
|
April 11, 2014
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates
Meng-Rui Lee, Jen-Chung Ko, Sheng-Kai Liang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
The Korean Journal of Internal Medicine
|
May 16, 2018
Albers-Schönberg disease
Li-Ta Keng, Sheng-Kai Liang
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
Sheng-Kai Liang, Jen-Chung Ko, James Chih-Hsin Yang, et al.
Analytical Biochemistry
|
March 17, 2023
Determining plasma and cerebrospinal fluid concentrations of EGFR-TKI in lung cancer patients
Guan-Yuan Chen, Sheng-Kai Liang, Yu-Feng Wei, et al.
ERJ Open Research
|
March 19, 2024
Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients with <i>EGFR</i>-mutated non-small cell lung cancer treated with afatinib
Sheng-Kai Liang, Pin-Fei Wei, Min-Shu Hsieh, et al.
Thorax
|
January 14, 2021
Pulmonary granulomas: give it a whorl
Li-Ta Keng, Wei-Yung Lo, Hsien-Neng Huang, et al.
International Journal of Antimicrobial Agents
|
August 24, 2015
Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014
Meng-Rui Lee, Chia-Jung Tsai, Sheng-Kai Liang, et al.
Oncotarget
|
November 23, 2017
Real-world experience of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma
Sheng-Kai Liang, Min-Shu Hsieh, Meng-Rui Lee, et al.
Journal of Bone and Mineral Metabolism
|
February 11, 2021
LncPVT1 promotes cartilage degradation in diabetic OA mice by downregulating miR-146a and activating TGF-β/SMAD4 signaling
Yan-Zhi Wang, Yao-Li, Sheng-Kai Liang, et al.
Oncotarget
|
May 29, 2018
Prognostic factors of afatinib as a first-line therapy for advanced <i>EGFR</i> mutation-positive lung adenocarcinoma: a real-world, large cohort study
Sheng-Kai Liang, Meng-Rui Lee, Wei-Yu Liao, et al.
International Journal of Antimicrobial Agents
|
April 11, 2014
Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: clinical features and susceptibilities of the isolates
Meng-Rui Lee, Jen-Chung Ko, Sheng-Kai Liang, et al.
Page
of 3